Brazilian authorities’ proven inability to prevent hormone-treated meat from entering the EU market

Priority question for written answer P-003045/2024/rev.1
to the Commission
Rule 144
Valérie Deloge (PfE), Julie Rechagneux (PfE), Angéline Furet (PfE), Anne-Sophie Frigout (PfE), Mathilde Androuët (PfE), Christophe Bay (PfE), France Jamet (PfE), Pascale Piera (PfE), Malika Sorel (PfE), André Rougé (PfE), Marie Dauchy (PfE), Gilles Pennelle (PfE)

On 16 October 2024, the Commission's Directorate-General for Health and Food Safety published an audit on the situation in Brazil 'to evaluate controls on residues of pharmacologically active substances, pesticides and contaminants in animals and animal products'. This audit clearly states that the arrangements put in place by Brazil to ensure that animals whose meat is destined for the EU market have not been treated with oestradiol 17β (a hormonal treatment prohibited in our livestock) are ineffective.

Therefore, neither the Brazilian Ministry of Agriculture nor the competent Brazilian health authorities can reliably attest that meat placed on the EU market complies with our health rules. Brazil has suspended its exports for now, but this decision is not enough.

• 1.Can the Commission affirm that it was not aware of this situation during the negotiations?
• 2.Can it guarantee that no control failures will come to light concerning other products?

Supporter[1]

Submitted: 19.12.2024

• [1] This question is supported by a Member other than the authors: Marie-Luce Brasier-Clain (PfE)